Case Study Part 2: Transforming Lung Cancer Screening with Veolity 🚀 Veolity: The Game Changer in Lung Cancer Screening Continuing from our previous post, we explore how University College London Hospitals NHS Foundation Trust (UCLH) leverages Veolity for precise and efficient lung diagnostics. Veolity, powered by deep-learning AI, enables radiologists to detect and assess different types of lung nodules more efficiently. This advanced software has enabled radiologists like Dr. Arjun Nair to read images 47% faster than manual processing, ensuring timely and accurate patient management. Dr. Arjun Nair highlights the device's ability to provide a clinical baseline and track finding progression over time, which is crucial for effective patient monitoring. Their integration of Veolity with UCLH’s electronic patient record system further streamlines the workflow, enhancing the overall efficiency of the lung screening process. Stay tuned for our final part, we'll discuss the broader impact of Veolity on radiology practices and lung cancer screening outcomes. Can’t wait to read the full study? Follow this link to download our case study together with SynApps Solutions Ltd: https://lnkd.in/e2M33GyD You are already interested in Veolity and want to know more? Contact us for more information: sales@mevis.de #Veolity #NHS #UCLH #lungcancerscreening #MeVis #VarexImaging #radiology #lungcancerdetection
MeVis Medical Solutions AG
Softwareentwicklung
Experts for medical software applications.
Info
MeVis Medical Solutions was founded in 1997 and is one of the world's leading independent developers and providers of software products for image-based medicine, particularly digital radiology. The importance and complexity of medical data acquired from today's imaging modalities like computer tomography, magnetic resonance tomography, ultrasound and mammography is growing steadily. MeVis products analyze and process this data to provide medical professionals crucial information for early diagnosis and therapy in the areas of cancer, particularly breast cancer, neurological disorders and lung conditions. The company develops its software solutions in close cooperation with world's leading clinical experts and has established longstanding industry partnerships with original equipment manufacturers (OEMs) of imaging devices and sells its products primarily through these channels. MeVis Medical Solutions AG recorded a revenue of 18.7 million € in fiscal year 2021/2022 and an average of 104 highly qualified employees. Data privacy regarding social media of MeVis Medical Solutions AG: https://www.mevis.de/en/data-privacy/data-privacy-social-media Site notice of MeVis Medical Solutions AG: https://www.mevis.de/en/imprint
- Website
-
http://www.mevis.de
Externer Link zu MeVis Medical Solutions AG
- Branche
- Softwareentwicklung
- Größe
- 51–200 Beschäftigte
- Hauptsitz
- Bremen
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Gegründet
- 1997
- Spezialgebiete
- medical imaging software, computer aided diagnosis, radiology, computer software und medical technology
Orte
-
Primär
Caroline-Herschel-Str. 1
Bremen, 28359, DE
Beschäftigte von MeVis Medical Solutions AG
Updates
-
Case Study Part 1: Pioneering AI-Driven Lung Screening at UCLH 🔍 University College London Hospitals NHS Foundation Trust (UCLH) Leads the Way in AI-Enhanced Lung Screening with Veolity Lung cancer remains the leading cause of cancer-related deaths globally, presenting a significant challenge for early detection. University College London Hospital is at the forefront of addressing this with cutting-edge AI and machine learning technologies. Their goal? To detect lung cancer earlier, improving patient outcomes, while alleviating the immense workloads of radiologists. Since 2017, Dr. Arjun Nair, a Consultant Radiologist specializing in cardiothoracic imaging at UCLH, has been utilizing an AI-powered lung screening solution. This journey began within a research setting and has since become a crucial component of NHS England’s National Lung Screening programme. Stay tuned as we delve deeper into the transformative impact of this technology in the next part. Can’t wait to read the full study? Follow this link to download our case study together with SynApps Solutions Ltd: https://lnkd.in/e2M33GyD Can’t wait to hear more about Veolity? Contact us for more information: sales@mevis.de #Veolity #NHS #UCLH #lungcancerscreening #MeVis #VarexImaging #radiology #lungcancerdetection
-
Today, we would like to highlight MeVis Distant Services (MDS) - our professional medical image analysis and data visualization service to support interdisciplinary evaluation of complex anatomy and surgery planning for oncologic patients and live liver donors. What does MeVis Distant Services do? Our experienced experts convert the information in your medical MRI and CT images into comprehensive anatomy visualizations of the liver, pancreas, and kidneys. We then provide our customers with detailed segmentation and interactive 3D models of the patient's individual complex anatomy. Our MeVis team is passionate about the frequent exchange with surgeons and transplantation experts about the developing needs in the operating room. MDS helps surgeons in the preoperative planning of complex oncological resections and living donor liver transplantations. For more information reach out to us at sales@mevis.de. #liver #liversurgery #oncology #anatomy #surgery #livertransplant #MeVis #VarexImaging
-
Das Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) hat im Auftrag des gemeinsamen Bundesausschusses (G-BA) die Nutzenbewertung für das Lungenkrebs-Screening mittels Niedrigdosis-Computertomografie aktualisiert. Das Ergebnis ist eindeutig: Der Nutzen und die Vorteile eines Screenings überwiegen das Risiko. Das Institut weist im Bericht auf den positiven Effekt des Verfahrens auf die lungenkrebsspezifische Mortalität sowie auf die Gesamtmortalität hin. Die gesamte Pressemitteilung des IQWiG könne Sie hier nachlesen: Lungenkrebsscreening mittels Low-Dose-CT: Starke Raucherinnen und Raucher können profitieren (iqwig.de) Unsere Software Veolity ist optimiert für das Lungenkrebs-Screening und wird bereits weltweit genutzt. Veolity unterstützt den Workflow, verkürzt die Lesezeit und hilft bei der Detektion und Volumetrierung von Lungenrundherden sowie der Berechnung der Volumenverdopplungszeit. Möchten Sie Veolity kennenlernen? Dann melden Sie sich bei uns: sales@mevis.de #Lungenkrebs #Früherkennung #MedTech #Veolity #Innovation #Gesundheit #Strahlenschutz #MeVis #VarexImaging
-
We're thrilled to share that we'll be at the EURO EVO DEVO 2024 in Helsinki, Finland from June 25-28! Visit us to explore MeVisLab, our powerful modular framework for image processing research, development and visualization. Discover its advanced software modules for segmentation, registration, volumetry, and functional analysis. Join us to learn more and see how MeVisLab can elevate your research projects! University of Helsinki #EuroEvoDevo #Helsinki2024 #MeVisLab #ImageProcessing #ResearchAndDevelopment #InnovationInScience #MeVis #VarexImaging
-
Two weeks ago, we had the pleasure to present and to train our MeVis Liver Suite to the transplant department and beyond at the Peyvan Hospital (Abu-Ali Sina Charity Hospital) in Shiraz. “Liver transplantations are not only a definitive way to cure advanced liver failure (cirrhosis), but it is also effective in treating some liver genetic disorders such as Crigler–Najjar syndrome.” (Abu-Ali Sina Charity Hospital, 2024) Our software MeVis Liver Suite, is a 3D liver surgery planning software for analysing DICOM CT and MRI images. It supports surgeons and radiologists in visualizing and quantifying anatomical details of their radiological image data to prepare their surgery in case of living donor liver transplantations as well as oncological resections. Thank you very much to Dr. Mohammad Bagher Khosravi, Dr.AliReza Rasekhi, Dr. Alireza Shamsaeefar and Dr. Alireza Shakibafard for having us! #MeVis #Arpamedical #MeVisLiverSuite #HealthTech #MedicalVisualization #LivingDonorLiverTransplantation #VarexImaging
-
Did you know there's an all-in-one e-learning platform for radiology training and quality control? Let’s talk about MeVis Online Academy. This advanced solution offers comprehensive user and data management, enabling access control, assessment statistics, and online exams. Accessible via any #web browser, it provides flexible learning opportunities #anywhere, #anytime. Medical centres, institutes, and companies can upload custom content, create courses, and share knowledge globally. Clinical experts can conduct courses and case discussions on various topics, including cardiology, mammography, lung/thorax, and prostate, at conferences and online. MeVis Online Academy can also be customized with site-specific branding and software development upon request. Get in touch with us for more information: sales@mevis.de #radiology #elearning #medicalsociety #medicalcenter #MeVis #VarexImaging #MeVisOnlineAcademy
-
Have you ever wondered how MeVisLab could revolutionize your approach to medical imaging? And did you know that there are over 3,490 published articles on Google Scholar exploring the vast realm of medical imaging? But why stop there? MeVisLab isn't just for students and researchers—it's also a game-changer for entrepreneurs, startups, and innovators looking for a cutting-edge advantage in medical imaging development. And for developers and programmers, MeVisLab offers a lightning-paced playground to experiment, integrate, and optimize algorithms. Are you ready to redefine the future of medical imaging research and development? Follow us on Instagram https://lnkd.in/eTaRd5rG or subscribe to our YouTube channel for more information: https://lnkd.in/ewB6thAF Feel free to contact us for more information: info@mevislab.de #MedicalImaging #InnovationInHealthcare #TechInnovation #Startups #CodingCommunity #MeVisLab #VarexImaging #Entrepreneur #Research #StartUp #Innovation
-
Schon gehört? Das Bundesministerium für Umwelt, Naturschutz, nukleare Sicherheit und Verbraucherschutz (BMUV) hat die rechtliche Grundlage für das Lungenkrebs-Screening in Deutschland geschaffen. Die neue Rechtsverordnung tritt am 1. Juli in Kraft und erlaubt das Screening mit Niedrigdosis-CT unter bestimmten Bedingungen. Dazu gehört auch, dass Radiologen eine entsprechende Software für die effiziente Befundung verwenden müssen. Und hier kommt Veolity in Spiel. Unsere Software Veolity unterstützt den Workflow, verkürzt die Lesezeit und hilft bei der Detektion und Volumetrierung von Lungenrundherden sowie der Berechnung der Volumenverdopplungszeit. Möchten Sie Veolity kennenlernen? Dann melden Sie sich bei uns: sales@mevis.de #Lungenkrebs #Früherkennung #MedTech #Veolity #Innovation #Gesundheit #Strahlenschutz #MeVis #VarexImaging
-
Reflecting on the past two years, a significant milestone was reached in British Columbia's fight against lung cancer. The initiation of the British Columbia Lung Screening programme marked a dedicated effort to detect lung cancer early in high-risk individuals through regular low-dose CT scans. This comprehensive program involves five health authorities and over 30 hospitals in more than 30 cities, collectively performing around 12,000 scans annually. To streamline this substantial workload, Veolity as a comprehensive workflow solution with end-to-end data management was established, ensuring an optimized screening process. Veolity focuses on supporting lung cancer diagnostics by realizing efficient and effective reading of chest CT scans for lung cancer screening. Reflecting on these facts, the British Columbia Lung Screening program's commitment to early detection is proving impactful in the fight against lung cancer. At MeVis, we understand the critical importance of early detection and offer the right solution. Veolity is our solution for effective lung cancer screening, contact us for further information: sales@mevis.de #EarlyDetectionMatters #Veolity #LungCancerScreening #AI #MeVis #Varex